NCT02081976

Brief Summary

Cardiovascular diseases (CVD) are still considered the main cause of mortality and morbidity all over the world. In the last years, efforts have been made to define more effective therapeutic and preventive strategies.Periodontal diseases have been considered a probable risk factor for CVD with a great amount of evidence from observational studies. Although there are some interventional studies evaluating the systemic effects of periodontal therapy, there is little information regarding the impact of periodontal treatment on the prevention of cardiovascular events. To the best of our knowledge, there are no randomized controlled trials published to date assessing the effect of periodontal therapy in primary prevention of CVD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Apr 2013

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 7, 2014

Completed
Last Updated

March 7, 2014

Status Verified

March 1, 2014

Enrollment Period

6 months

First QC Date

March 6, 2014

Last Update Submit

March 6, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Traditional cardiovascular risk markers (total cholesterol, LDL-C, HDL-C and triglycerides)

    Change from baseline to six month

Secondary Outcomes (2)

  • High- and low-density lipoprotein cholesterol

    Change from baseline to six month

  • cardiovascular risk scores (Framingham)

    Change from baseline to six months

Other Outcomes (1)

  • Blood Pressure and Sugar

    Change from baseline to six months

Study Arms (2)

Standard Care Group

ACTIVE COMPARATOR

Dental therapist providing standard periodontal treatment

Other: Standard Care Group

Integrated Care Group

EXPERIMENTAL

a combined treatment approach of Dental Therapist, Dental Hygienist, Cardiologist along with counselor

Behavioral: Integrated Care Group

Interventions

The group (TG) consisted of periodontal treatment comprising one session of supragingival scaling and personalized oral hygiene instructions, followed by one to four sessions of subgingival scaling and root planing (SRP) by quadrant, under local anesthesia, in a period of 14 days. Individuals were be followed monthly during the first 6 months. In the follow-up sessions, professional plaque removal, oral hygiene instructions, cardiac support along with counseling reinforcement were be provided.

Integrated Care Group

The group (TG) comprising one session of supragingival scaling followed by one to four sessions of subgingival scaling and root planing (SRP) by quadrant, under local anesthesia, in a period of 14 days.

Standard Care Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals having at least 50% of their dentition with periodontal probing pocket depths N4 mm and
  • With documented radiographic alveolar bone loss were included

You may not qualify if:

  • Known systemic diseases
  • History and/or presence of other infections
  • Systemic antibiotic treatment in the preceding 3 months
  • Treatment with any medication known to affect the serum level of inflammatory markers, lipids, or BP
  • Pregnant or lactating females
  • Allergy to tetracyclines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GyanSanjeevani

Jaipur, Rajasthan, 302019, India

Location

MeSH Terms

Conditions

PeriodontitisCoronary Disease

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Neelam Maheshwari, BDS

    Maheshwari Dental Clinic

    PRINCIPAL INVESTIGATOR
  • Neha Sharma, PhD

    Macmillan Research Group

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2014

First Posted

March 7, 2014

Study Start

April 1, 2013

Primary Completion

October 1, 2013

Study Completion

January 1, 2014

Last Updated

March 7, 2014

Record last verified: 2014-03

Locations